Person | Loss | Gain | Total | Notable loss | Notable gain | With Axis | Plausible association |
---|---|---|---|---|---|---|---|
Aa | 289 | 55 | 344 | GATA2, ELK1, GSTM4, GPX4 | KCNJ2, PTGR2, F8, LMNB1 | Low Axis 1 | Calcitrol responsive genes with low blood calcium |
Low Axis 1 with low lymphocyte count | |||||||
Ab | 40 | 38 | 78 | SLC2A9, ITGB2 | TUBB1, CD59 | High Axis 7 | Diabetic: low sugar transporters with high blood glucose |
Predicted homocystinurea risk with low glutathione and cysteine-glutathione | |||||||
High tubulin 1 with high platelet count | |||||||
Ac | 38 | 17 | 55 | ALS2, SMPD1 | |||
Ad | 128 | 61 | 189 | FUCA1, FUT4, FUT7, CA2 | CR2, CD19, CD72, RETN | High Axis 3 | Low CA2 with sleep disorder |
High Axis 3 with B cell activation | |||||||
Protection against type 2 diabetes from resistin, fucosidases | |||||||
Ce | 46 | 36 | 82 | SPG7, ERCC3, COL5A3, GSTM2 | High Axis 6 | ||
Cf | 19 | 41 | 60 | TPM1, KCNH2, SIAE, IRAK3 | High Axis 5 | Negative regulation of immunity with high IL6, IL8 | |
High TPM1, KCNH2 with hypertension | |||||||
Cg | 0 | 1 | 1 | ||||
Ch | 28 | 65 | 93 | GSTP1, MTHFR, TNF, CEBPA | |||
Mi | 38 | 80 | 118 | ADSL, GNE, ARMD3, DISC1 | CLN6, FTL | Low Axis 6 | FTL with high ferritin, total iron capacity |
High Axis 2 | High Axis 2 with high red blood cell count | ||||||
Mj | 17 | 31 | 48 | F5, FCGR2C, FCGR3A, FCGR3B, LILRA4 | CD8A, CCR5, IL2RB, IL12RB2 | High Axis 1 | Unusual profile predicts aberrant immune signaling |
Mk | 3 | 9 | 12 | SNTA1, FADS2, COCH | |||
Ml | 14 | 12 | 26 | FANCA, SIDT2, SLC22A18 | ENC1 | Low Axis 3 | Four genes are biomarkers of leukemia in the observed direction |